Target intelligence / Profile preview

Bacterial cell wall precursor Lipid II (Lipid II)

Target
Lipid II
Molecular classification
Glycolipid, Peptidoglycan precursor, Bacterial cell wall component
01

Overview

Bacterial cell wall precursor Lipid II is an essential, low-abundance intermediate in the biosynthesis of peptidoglycan, the primary structural component of the bacterial cell wall (Münch & Sahl, 2015, Nature Reviews Microbiology). It consists of a disaccharide (N-acetylglucosamine and N-acetylmuramic acid) with a pentapeptide chain, linked to a C55 undecaprenyl lipid carrier via a pyrophosphate bridge (Breukink & de Kruijff, 2006, Nature Reviews Drug Discovery). Lipid II is synthesized on the inner leaflet of the cytoplasmic membrane and subsequently flipped to the outer leaflet, where it serves as the substrate for transglycosylases and transpeptidases (Schneider & Sahl, 2010, Applied Microbiology and Biotechnology). Because Lipid II is highly conserved across Gram-positive and Gram-negative bacteria and is vital for maintaining cell integrity, it is a prime target for various antibiotic classes. Drugs like vancomycin bind to the D-Ala-D-Ala terminus of the pentapeptide, while newer agents like teixobactin target the pyrophosphate and sugar moieties, effectively halting cell wall construction and leading to bacterial lysis (Ling et al., 2015, Nature). Its role as a bottleneck in cell wall synthesis makes it an effective target for overcoming certain types of antibiotic resistance.

Other names
Undecaprenyl-pyrophosphoryl-MurNAc-(pentapeptide)-GlcNAcLipid 2Bactoprenol-pyrophosphate-MurNAc-pentapeptide-GlcNAcPeptidoglycan precursor Lipid II
02

Mechanism of action

Inhibition of cell wall synthesis by binding to the Lipid II precursor, thereby blocking the transglycosylation and transpeptidation steps of peptidoglycan polymerization.

03

Biological functions

Peptidoglycan biosynthesisCell wall assemblyBacterial cell division
04

Disease associations

Bacterial infection
05

Safety considerations

NephrotoxicityOtotoxicityInfusion-related reactions (e.g., Red Man Syndrome)Antibiotic resistance development (e.g., VRE, VRSA)
06

Interacting drugs

Vancomycin

9 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial loadSerum drug levels

Beyond the preview

Go deeper on Bacterial cell wall precursor Lipid II (Lipid II).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall precursor Lipid II (Lipid II).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call